Facilitated By

San Antonio Medical Foundation

Randomized Trial Of SPI-2012 Versus Pegfilgrastim In The Management Of Chemotherapy Induced Neutropenia In Breast Cancer Patients Receiving Docetaxel And Cyclophosphamide (TC) (Advance)

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
GENEVA
Research Start Date
Status
Active

The study will compare the efficacy and safety of SPI-2012 with pegfilgrastim in patients with early-stage breast cancer receiving TC chemotherapy.

Clinical Care
Cancer
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.